Pharvaris
Leandri Heystek is a highly accomplished individual with a background in pharmaceutical chemistry and pharmacy. Currently working as a Senior Operations Manager at Pharvaris, Leandri previously held positions such as a PhD student at North West University Potchefstroom Campus where groundbreaking research in pharmaceutical chemistry, drug design, and Alzheimer's disease was conducted. Leandri also has experience as a Community Service Pharmacist at Zamdela CHC Sasolburg and has worked as a locum pharmacist at various pharmacies in the past. With a Bachelor's degree in Pharmacy and advanced degrees in pharmaceutical chemistry, Leandri is a dedicated professional in the field.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.